The Bill and Melinda Gates Foundation has announced a three-year, $6.5 million grant to Family Health International to fund a clinical trial to evaluate whether the anti-HIV drug Viread is effective at reducing the risk of HIV infection among sexually active adults regularly exposed to the virus. The drug had been shown to boost immune response and to lower viral levels in the blood of HIV-positive people resistant to other anti-HIV medications. The new study will evaluate whether a once-daily dose of Viread can reduce the risk of HIV infection among HIV-negative adults in developing nations with high HIV infection rates. The foundation also awarded a $3 million grant to the Johns Hopkins University School of Medicine to help develop community-based tuberculosis prevention strategies in areas of high HIV prevalence.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved














Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes
These are some of his worst comments about LGBTQ+ people made by Charlie Kirk.